Providence launched the groundbreaking Geno4ME study because we believe in the promise of genomic medicine to help understand people on an individual level and to redefine the future of personalized care. The mission of Geno4ME, and of Genomics at Providence, is to increase the role of genomics for improving disease prevention and treatment.
Providence will enroll thousands of patients into the Geno4ME study. All participants will undergo whole genome sequencing and answer health questionnaires. This, along with their electronic health records, will create a unique medical portrait of each participant in the study. Participants and their healthcare provider will learn about their risks, if any, for certain inherited diseases that have clear recommendations for prevention and treatment. They will also learn if they have clinically actionable pharmacogenomic results for selected medications.